Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; TX200, a chimeric antigen receptor engineered regulatory T cell (CAR-Treg) therapy product candidate that is in Phase 1/2 clinical study for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation; and SB-525, a gene therapy product candidate, which is in Phase 3 clinical trial for the treatment of moderately severe to severe hemophilia A. Its preclinical development products focus on tauopathies, ALS/FTD, and huntington's diseases Sangamo Therapeutics, Inc. has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi S.A.; Novartis Institutes for BioMedical Research, Inc.; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; and Open Monoclonal Technology, Inc. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. The company was incorporated in 1995 and is headquartered in Richmond, California.

Sangamo Therapeutics Inc.

The Vanguard Total Stock Market ETF ($VTI), which tracks the broader U.S. stock market, is up by 0.83% in early trading on Thursday as investor opt...

Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/14/26?

The Vanguard Total Stock Market ETF ($VTI), which tracks the broader U.S. stock market, was slightly higher on Wednesday as investors grew more opt...

Why Is Vanguard Total Stock Market (VTI) ETF Up Today, 5/13/26?

The Vanguard Total Stock Market ETF ($VTI), which tracks the broader U.S. equity market, rose 0.66% at Friday’s open as investors reacted to geopol...

Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/8/26?

The Vanguard Total Stock Market ETF ($VTI), which tracks the broader U.S. equity market, rose 0.76% at the market open on Wednesday. Investor senti...

Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/6/26?

The Vanguard Total Stock Market ETF ($VTI), which tracks the broader U.S. equity market, rose 0.53% in pre-market trading on Tuesday. Investors lar...

Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/5/26?

Vanguard Total Stock Market ($VTI), which tracks the broader U.S. market, was little changed in pre-market trading on Monday, down about 0.014% as ...

Why Is Vanguard Total Stock Market (VTI) ETF Down Today, 5/4/26?

Vanguard Total Stock Market ETF ($VTI), which tracks the broader U.S. market, opened 0.50% higher on Friday as investors digested Big Tech earnings...

Why Is Vanguard Total Stock Market (VTI) ETF Up Today, 5/1/26?

Vanguard Total Stock Market ETF ($VTI), which tracks the broader U.S. market, opened 0.31% higher on Thursday as investors reacted to strong Big Te...

Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 4/30/26?

We’ve identified three of the best cheap stocks to buy today. Price is important to us all, especially during tough economic times. That is true in...

3 Best Cheap Stocks to Buy Now: 04/29/26

The Vanguard Total Stock Market ETF ($VTI), which tracks the broader U.S. market, is down 0.014% at Monday’s open as markets prepare for major tech...

Why Is Vanguard Total Stock Market (VTI) ETF Down Today, 4/27/26?

Insiders have been trading these 5 stocks: (($HSY)), (($SGMO)), (($CTAS)), (($RDW)) and (($TOST)). Here is a breakdown of their recent trades and t...

Hershey, Sangamo, Cintas, Redwire, Toast Insider Shake-Up

The Vanguard Total Stock Market ETF ($VTI), which tracks the broader U.S. stock market, rose about 0.93% at Wednesday’s open. The move followed new...

Why Is Vanguard Total Stock Market (VTI) ETF Up Today, 4/22/26?

The Vanguard Total Stock Market ETF ($VTI), which tracks the broader U.S. stock market, rose 0.21% at the open on Thursday, April 16, 2026, as inve...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	SGMO	$0.14	-0.37%	4.17M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	SGMO	$0.14	-0.4%	4.17M
3
4
5
6

SGMO

SGMO

Get Sangamo Therapeutics Inc. Data in Excel

Get Sangamo Therapeutics Inc. Data in Excel